07/13/2026
The future of hair loss treatment is looking bright! For more than 30 years, treatment options for androgenetic alopecia (male and female pattern hair loss) have largely revolved around a small group of core medications: minoxidil and antiandrogens (finasteride/dutasteride, spironolactone).
While these remain excellent treatments for many patients, the next generation of therapies is taking a completely different approach.
So what’s around the corner?
Researchers are studying a variety of new medications that work quite differently from our current standard treatments.
1. Some block androgen receptors directly rather than simply lowering DHT. Clascoterone is a topical androgen receptor antagonist that blocks DHT from activating the follicle. GT20029 is a compound that targets the androgen receptor for degradation, removing the “lock” that DHT normally binds to.
2. Others target entirely new hormonal pathways. Medications such as HMI-115 are investigating whether blocking prolactin signaling can promote hair growth—a completely different approach from traditional anti-androgen therapies.
3. Several therapies aim to wake up dormant hair follicles. Drugs like PP405 are designed to activate resting follicle stem cells by altering their metabolism. Rather than simply slowing hair loss, the goal is to encourage follicles to begin producing hair again.
4. Regenerative injectable therapies, including AMP-303, are being developed to stimulate follicles to re-enter the active growth (anagen) phase.
5. Researchers are also exploring therapies that target cellular metabolism, thyroid hormone signaling, potassium channels, and even biological aging pathways using medications such as rapamycin and metformin.
It’s important to remember that many of these therapies are still in clinical trials and some may never make it to the real world for use by patients. Some may make it to market but will need to prove themselves against current therapies. I believe we’re entering one of the most exciting eras in hair loss research!
Reference of Interest
Agrawal A et al. Emerging pharmacotherapies for androgenetic alopecia. Expert Opin Pharmacother. 2026.
